Bladder Cancer Treatment

Radical Cystectomy — Open / Laparoscopic / Robotic

Surgical Removal of the Bladder for Muscle-Invasive or High-Risk Bladder Cancer with Urinary Diversion

4–8 Hours PROCEDURE
7–14 Days HOSPITAL STAY
>80% 5yr SUCCESS RATE
6–8 Weeks RECOVERY

What is Radical Cystectomy — Open / Laparoscopic / Robotic?

Radical Cystectomy is the gold-standard surgical treatment for muscle-invasive bladder cancer (MIBC) and high-risk non-muscle-invasive disease. It involves complete removal of the bladder, prostate (in men), uterus and anterior vaginal wall (in women), and regional lymph nodes, followed by urinary diversion — either an ileal conduit for external drainage or orthotopic neobladder for natural voiding. The procedure can be performed via open, laparoscopic, or robotic-assisted approaches, all achieving equivalent oncological outcomes. Neoadjuvant cisplatin-based chemotherapy improves survival by 5–10% and is recommended before surgery. The procedure is performed under general or spinal anaesthesia with a hospital stay of 7–14 Days.

Patients with muscle-invasive bladder cancer (T2–T4), BCG-unresponsive high-grade NMIBC, carcinoma in situ unresponsive to BCG, or extensive recurrent high-risk NMIBC. Patients must be adequately fit for anaesthesia and free from active systemic infection before proceeding.

How the Procedure Works

1

Approach & Bladder Mobilisation

Robotic, laparoscopic, or open approach; bladder, prostate or uterus mobilised and removed en bloc with regional lymph nodes.

2

Extended Pelvic Lymph Node Dissection

Extended pelvic lymph node dissection performed simultaneously for staging and therapeutic benefit.

3

Urinary Diversion Construction

Ureters divided; urinary diversion selected and constructed — ileal conduit (urostomy) or orthotopic neobladder (natural voiding).

4

Anastomoses & Drainage

All anastomoses completed; drains, catheters, and stents placed.

5

Recovery & Discharge

Patient discharged when bowel function returns and adequate drainage confirmed — typically day 7–14.

Outcomes

4–8 HoursDURATION
7–14 DaysHOSPITAL STAY
>80% 5yrSUCCESS RATE
6–8 WeeksFULL RECOVERY

Who Needs This Treatment?

  • Gold standard curative treatment for muscle-invasive TCC and high-risk NMIBC.
  • Extended lymph node dissection improves staging accuracy and survival.
  • Choice of urinary diversion tailored to patient anatomy, preference, and fitness.
  • Neoadjuvant chemotherapy before surgery improves survival outcomes by 5–10%.
  • Robotic approach reduces blood loss and shortens hospital stay in experienced centres.
  • Eliminates the bladder reducing recurrence risk from retained urothelium.
"

"Radical cystectomy with urinary diversion is a major operation — but for muscle-invasive TCC, it offers the best chance of cure. Our goal is to remove every cancer cell while preserving the highest possible quality of life through careful diversion selection."

— — Dr. Vipin Reddy, Consultant Urologist, Andrologist & Renal Transplant Surgeon

Common Questions

Frequently Asked

Not sure which treatment is right for you?

Book a consultation with Dr. Vipin Reddy and get a personalised treatment plan.

WhatsApp Book Now Directions

Language